Emily Mould
-
- Peptidase Inhibition and Analysis 2
-
- Health Policy Implementation Science 4
-
- IgG4-Related and Inflammatory Diseases 2
-
- Neuroendocrine Tumor Research Advances 2
-
- Childhood Cancer Survivors' Quality of Life 2
-
- DNA Repair Mechanisms 2
-
- Acute Lymphoblastic Leukemia research 2
-
- Health Systems, Economic Evaluations, Quality of Life 2
- Co-authors
- Vanessa TyrrellJames SmithJeffrey BraithwaiteFrances RapportJanet C. LongTracey O’BrienGlenn M. MarshallAndrew J. Gifford
- Cited by
- GeneticsNeurologyToxicology
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Emily Mould
11 papers receiving 212 citations
Peers
Comparison fields: 5 of 61
- Genetics 55
- Neurology 48
- Toxicology 9
- Oncology 57
- Cancer Research 22
Countries citing papers authored by Emily Mould
This map shows the geographic impact of Emily Mould's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Mould with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Mould more than expected).
Fields of papers citing papers by Emily Mould
This network shows the impact of papers produced by Emily Mould. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Mould. The network helps show where Emily Mould may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emily Mould, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 8 | |
| 2 | 2022 | 4 | |
| 3 | 2020 | 21 | |
| 4 | 2020 | 13 | |
| 5 | 2020 | 36 | |
| 6 | 2019 | 1 | |
| 7 | 2018 | 81 | |
| 8 | 2017 | 5 | |
| 9 | 2016 | 1 | |
| 10 | 2014 | 13 | |
| 11 | 2011 | 30 |
About Emily Mould
Emily Mould is a scholar working on General Health Professions, Oncology and Cancer Research, having authored 11 papers that have together received 213 indexed citations. Recurring topics across this work include Health Policy Implementation Science (4 papers), IgG4-Related and Inflammatory Diseases (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Peptidase Inhibition and Analysis (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers), DNA Repair Mechanisms (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Genetics (55 citations), Neurology (48 citations) and Toxicology (9 citations). Emily Mould has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Vanessa Tyrrell, James Smith, Jeffrey Braithwaite, Frances Rapport, Janet C. Long, Tracey O’Brien, Glenn M. Marshall, Andrew J. Gifford, Stephanie Smith and Michelle Haber. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.